Over the entire study, the cumulative incidence was 27% lower for the lifestyle group than for the placebo group p diabetes, with 1. Diabetes prevention program research group 2012 longterm safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study. Diabetes prevention program outcomes study the diabetes prevention program outcomes study dppos, the 10year followup study to the dpp, has closely followed 88 percent of the surviving dpp participants who were eligible to join. The followup study, the diabetes prevention program outcomes study dppos, was initiated in 2002 to measure the longterm effects of interventions used in the dpp study on the development of type 2 diabetes and associated complications. Jun 05, 2002 diabetes prevention program research group. The diabetes prevention program dppa major clinical trial involving 3,234 people with impaired glucose tolerance, a condition that often precedes diabetes demonstrated that some people at high risk for type 2 diabetes can prevent or delay the onset of the disease by losing 5 percent to 7 percent of their body weight and getting 30. Regression from prediabetes to normal glucose regulation and. The followup cohort, the diabetes prevention program outcomes study dppos, is in its 15th year and has continued to ascertain incident diabetes as well as diabetes complications.
The national diabetes prevention program national dpp is rapidly expanding in an effort to help those at high risk of type 2 diabetes prevent or delay the disease. Participants in the placebo and metformin groups were offered group intensive. Type 2 diabetes prevention evidence summary randomized clinical control trials. In an observational analysis, we examined whether regression to ngr also reduced risk for microvascular disease mvd. In the diabetes prevention program outcomes study dppos, type 2 diabetes was not associated with cognition, although higher hba1c was related to decreased cognitive function after adjusting for. The national diabetes prevention program ndpp is a widely disseminated translation of the highly successful lifestyle change intervention from the diabetes prevention program research study 5,6. Over the entire study, the cumulative incidence was 27% lower for the lifestyle group than for the placebo group p study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the version 4. Longterm metformin use and vitamin b12 deficiency in the. Metformin and type 2 diabetes prevention diabetes spectrum. Although these dpp translations have consistently shown favorable clinical outcomes, longterm data for digital formats are limited.
Engagement and outcomes in a digital diabetes prevention. Objective the diabetes prevention program dpp and its outcomes study dppos demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in highrisk adults for at least 10 years after randomization. In the dppdppos, persons at high risk for type 2 diabetes have been continued on randomized metformin treatment for over 10 years. The diabetes prevention program dpp was a major clinical trial, or research study, aimed at discovering whether either diet and exercise or the oral diabetes drug metformin glucophage could prevent or delay the onset of type 2 diabetes in people with impaired glucose tolerance igt. The dpp was conducted in a cohort at high risk for the development of diabetes on the basis of.
Diabetes prevention program outcomes study study documents go back to all study documents index of forms. The diabetes prevention program dppdpp outcomes study dppos represents one of the largest and longest studies of metformin treatment. Longterm effects of lifestyle intervention or metformin on. During the first 7 years of the diabetes prevention program outcomes study dppos, diabetes incidence rates, when compared with the diabetes prevention program dpp, decreased in the placebo. The dpp enrolled participants over a 3year period ending june 1999, therefore participants had varying duration of dpp followup depending on their year of. Factors affecting the decline in incidence of diabetes in the. The longterm followup study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the scientifically and clinically valuable cohort of dpp volunteers and the large volume of data.
Diabetes prevention program outcomes study phase 1 data release october 2011 4 of 22 1. The clinical intervention consists of a minimum of 16 intensive core sessions of a centers for disease control and prevention cdc approved curriculum furnished. Lipid profile was measured annually, with statin treatment determined by a participants own physician. Objective regression from prediabetes to normal glucose regulation ngr was associated with reduced incidence of diabetes by 56% over 10 years in participants in the diabetes prevention program outcomes study dppos. This studys objective was to examine clinical outcomes up to 3 years postbaseline and the relationship. The largest and longest clinical trial of metformin for the prevention of diabetes is the diabetes prevention program diabetes prevention program outcomes study dppdppos. To allow nih to identify a group of applications as a related set of collaborative applications, the titles for each application in the set must have the following format.
Diabetes prevention program outcomes study dppos highlights. Diabetes prevention program outcomes study study documents. The dppos was designed to examine the longerterm impact of the original treatment interventions. Research design and methods data on resource utilization, cost, and quality. Dppos is by far the largest of the diabetes prevention studies with a cohort randomly assigned to metformin.
The cdc developed the national diabetes prevention program ndpp, a publicprivate partnership working to offer evidencebased, costeffective interventions across the us with the goals of reducing the growing problem of prediabetes and type 2 dm as well as to build on the dpp trial. Evaluation of a digital diabetes prevention program adapted. The diabetes prevention program dpp, funded by the national institute of diabetes and digestive and kidney diseases niddk and conducted at 25 centers nationwide, was a landmark trial to show that lifestyle changes or metformin can effectively delay diabetes in a diverse population of overweight or obese american adults at high risk of diabetes in the short term and long term compared to. The diabetes prevention program research group conducted a large, randomized clinical trial involving adults in the united states who were at high risk for the development of type 2 diabetes. Study protocol and statistical analysis plan pdf may 22, 2019. The longterm followup study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the version 4. Longterm weight loss with metformin or lifestyle intervention in. Research design and methods generalized estimating. Medicare diabetes prevention program mdpp expanded model. Diabetes prevention program outcomes study full text view.
Power up for healthparticipants perspectives on an adaptation of the national diabetes prevention program to. Standardsofmedicalcareindiabetes 2020 abridged for. Diabetes prevention program outcomes study full text. Metformin, lifestyle intervention, and cognition in the. Diabetes prevention program fact sheet national kidney. Its outcomes study dppos observed patients after the masked treatment phase ended. Using a reaim framework to identify promising practices. The diabetes prevention program dpp was a major clinical trial. This foa invites collaborative u01 cooperative agreement applications from the diabetes prevention program outcomes study dppos biostatistics research center brc to undertake continued followup of the dppos cohort. Diabetes prevention program outcomes study dppos niddk. Longterm effects of lifestyle intervention or metformin.
The diabetes prevention program dpp 1 showed that intensive lifestyle intervention and metformin administration reduced diabetes incidence compared with placebotreated control subjects. The dpp diabetes prevention program was a randomized controlled trial that compared weight loss with metformin, intensive lifestyle intervention ils, or placebo. The diabetes prevention program dpp, funded by the national institute of diabetes and digestive and kidney diseases niddk and conducted at 25 centers nationwide, was a landmark trial to show that lifestyle changes or metformin can effectively delay diabetes in a diverse population of overweight or obese american adults at high risk of. Nov 14, 2009 the diabetes prevention program outcomes study dppos is a longterm followup of the dpp to investigate whether the delay in development of diabetes seen during the dpp can be sustained and to assess longterm effects of the interventions on health. Longterm safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study. The diabetes prevention program outcomes study dppos, the 10year followup study to. Conclusion overall, intensive lifestyle intervention achieved, with less medication, a comparable long. Reduction in the incidence of type 2 diabetes with lifestyle. Research design and methods during the diabetes prevention program outcomes study n3234, the longterm followup to a randomized clinical trial of interventions to prevent t2dm, incident diabetes was assessed by annual 75 g oral glucose tolerance testing and semiannual fasting glucose. Request pdf longterm weight loss with metformin or lifestyle intervention in the diabetes prevention program outcomes study. Reduction in the incidence of type 2 diabetes with.
Realmuto l, kamler a, weiss l, garywebb tl, hodge me, pagan ja, et al. The diabetes prevention program dpp 1 and its followup, the diabetes prevention program outcomes study dppos 2,3, have demonstrated the bene. The diabetes prevention program research group thanks the participants of the diabetes prevention program and diabetes prevention program outcomes study for their commitment and dedication. Longterm safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study the diabetes prevention program research group diabetes care apr 2012, 35 4 731737. May 21, 2019 the dpp diabetes prevention program was a randomized controlled trial that compared weight loss with metformin, intensive lifestyle intervention ils, or placebo. In 2012, the centers for disease control and prevention funded six national organizations to scale and sustain multistate delivery of the national dpp lifestyle change intervention lci. The diabetes prevention program dpp was a randomized controlled trial which enrolled overweight and glucoseintolerant participants. National diabetes education program ndep 19882019 working with local and national partners, ndep sought to improve the treatment and outcomes for people with diabetes, promote early diagnosis, and prevent or delay the onset of type 2 diabetes. Evaluation of a digital diabetes prevention program. Exploring residual risk for diabetes and microvascular. There is strong and consistent evidence from randomised controlled trials that type 2 diabetes can be prevented or delayed through lifestyle modification which improves diet, increases. Objective translations of the diabetes prevention program dpp have proliferated in recent years, with increasing expansion to digital formats. Most in the diabetes prevention program and diabetes prevention program outcomes study. Partners make it easier for people at risk for type 2 diabetes to participate in evidencebased lifestyle change programs to reduce their risk of type 2 diabetes.
The 10year costeffectiveness of lifestyle intervention. Prevention is an essential component of strategies to reduce the diabetes burden. Longterm effects of metformin on diabetes prevention. The protocol is maintained by the coordinating center coc at the george washington university biostatistics center through new releases of the entire protocol or issuance of supplemental protocol memoranda. Longterm metformin use and vitamin b12 deficiency in the diabetes prevention program outcomes study vanita r. Case reports on diabetesrelated outcomes for pregnant women.
Diabetes prevention program outcomes study data release. The medicare diabetes prevention program expanded model is a structured intervention with the goal of preventing type 2 diabetes in individuals with an indication of prediabetes. Limited competition for the continuation of the diabetes prevention program outcomes study. The diabetes prevention program dpp and dpp outcomes study dppos periods, and the overlap between them, are shown. The national diabetes prevention program ndpp is a partnership between the cdc and private organizations working to reduce diabetes in the u. Nov 27, 2019 the dpp used in this study achieved full recognition status from the centers for disease control and preventions diabetes prevention recognition program 21.
At the end of the 3 years of active intervention, the dpp was closed and was converted to a longterm followup study, the dpp outcomes study dppos, to determine whether the. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes. Infertility, gravidity, and risk of diabetes among high. The national diabetes prevention program lifestyle intervention curriculum is based on the curriculum from the diabetes prevention program dpp research study supported by the national institutes of health, national institute of diabetes and digestive and. The application submitted under this foa is linked to rfadk20501 which will support the dppos clinical centers. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Type 2 diabetes is a major public health problem in australia with prevalence increasing in parallel with increasing obesity. We report the 10year withintrial costeffectiveness of the interventions. The diabetes prevention program outcomes study dppos is a longterm followup of the dpp to investigate whether the delay in development of diabetes seen during the dpp can be sustained and to assess longterm effects of the interventions on health.
Longterm effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15year followup. The diabetes prevention program dpp showed that intensive lifestyle intervention and metformin administration reduced diabetes incidence compared with placebotreated control subjects. The dpp showed that people who are at high risk for type 2 diabetes can prevent or delay the disease by losing a modest amount of weight through lifestyle changes dietary changes and increased physical activity. Factors affecting the decline in incidence of diabetes in. At the end of the 3 years of active intervention, the dpp was closed and was converted to a longterm followup study, the dpp outcomes study dppos, to. The national diabetes prevention program national dpp is a partnership of public and private organizations working to prevent or delay type 2 diabetes. Regression from prediabetes to normal glucose regulation.
688 605 913 37 1552 1317 113 1315 1228 975 1203 1103 243 54 89 347 281 430 546 189 1469 1534 1486 431 1048 973 533 735 658 83